CAT vs NRXPW · P/E 48, rev $37.96B vs rev $242.0K
Caterpillar Inc (CAT) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the CAT and NRXPW stock pages for the full models.
Not investment advice.